The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, D.
Right arrow Articles by Coleclough, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, D.
Right arrow Articles by Coleclough, C.
The Journal of Immunology, 1999, 163: 4673-4682.
Copyright © 1999 by The American Association of Immunologists

TH Cells Primed During Influenza Virus Infection Provide Help for Qualitatively Distinct Antibody Responses to Subsequent Immunization1

Dana Marshall, Robert Sealy, Mark Sangster and Christopher Coleclough2

Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The quality of the primary Ab-forming cell (AFC) response in cervical lymph nodes and mediastinal lymph nodes of mice to intranasal influenza virus was strongly influenced by viral replicative capacity. IgA secretors were prominent in the early AFC response to infectious virus in mediastinal lymph nodes, while IgG expression was more frequent among isotypically switched AFC in cervical lymph nodes of the same mice; this pattern was reversed in the response to inactivated virus. Influenza viruses A/PuertoRico/8/34 (A/PR8) and A/X-31 share six of eight genome segments, differing only in hemagglutinin (H1 in A/PR8, H3 in A/X-31) and neuraminidase (N1 in A/PR8, N2 in A/X-31) genes. These viruses therefore elicit extensively cross-reactive TH populations, though their glycoproteins are serologically unrelated. Mice recovered from an A/X-31 infection thus mount a primary B cell response against A/PR8 glycoproteins, when challenged with the latter virus, though this response can call upon memory TH cells. To assess the impact of memory TH populations on a primary Ab response, we compared the AFC response to inactivated A/PR8 in naive mice and mice that had cleared an A/X-31 infection. A/X-31 immune mice mounted a more vigorous AFC response against A/PR8 H1 and N1 glycoproteins than naive animals, when immunized intranasally with inactivated A/PR8. However the distribution of isotypes among H1/N1-specific AFC in lymph nodes of A/X-31-primed mice resembled that of naive mice. Evidently, in this functional context, memory TH cells retained the ability to help Ab responses different in quality from that generated during their primary reaction.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Antibodies play a critical role in controlling the multitudes of diverse microbial parasites and viruses that continually assail the body surfaces of vertebrates. The effectiveness of this control depends not only on the amounts and affinities of such Abs, but also on the "quality" of the response, determined by the relative contribution of each Ab class, with its particular set of effector functions. The multiplicity of isotypes available to mammals implies the existence of regulatory mechanisms that govern the mutually exclusive choice among isotypes that B cells engaged in an immune response must make. A large mass of data supports the notion that isotype expression in B cells responding to a novel antigenic challenge is determined primarily by the pattern of lymphokines secreted by Ag-specific helper T cells (1), and current opinion holds that such T cells become committed to definite patterns of lymphokine secretion early in their response (2).

While B cells effectively recognize the native folded structure of protein Ags, they collaborate with TH cells that recognize composite surfaces of antigenic peptide fragments and MHC class II molecules. Moreover, there is no predictable physical association between B and TH epitopes: B cells specific for influenza hemagglutinin (H)3, for example, can receive help from TH cells reactive with peptides within the hemagglutinin molecule, or from TH cells specific for epitopes within other viral proteins (3). These categorical distinctions between the antigenic structures recognized by B and by TH cells make it conceivable that naive B cells, responding to a novel Ag, might obtain help from TH cells previously primed by encounter with some completely separate antigenic form. That this is more than just a formal possibility is suggested by abundant experimental evidence and supporting theoretical arguments that imply large scale redundancy of recognition among TH cells (4): a given peptide/MHC class II complex can be recognized by a diversity of TCRs, and a given TCR can recognize a diversity of peptide/MHC class II complexes.

If TH cells become irreversibly committed to the secretion of definite patterns of lymphokines, which in turn govern isotype commitment by B cells collaborating with those TH cells, then we may expect the quality of an individual’s Ab response to a newly encountered Ag to depend upon the extent to which naive B cells collaborate with existing memory TH populations, and thus upon the history of that individual’s encounter with immunogens cross-reactive with the new Ag at the TH level. Indeed this is the heart of the "molecular mimicry" theory of immunopathological disease, as it applies to Ab responses (5).

Here we make use of the segmented genetic structure of influenza A viruses to determine the impact upon the quality of a new antiviral Ab response of a memory TH population previously primed by Ag encounter under qualitatively distinct circumstances. Use of the influenza viral strains influenza virus A/HK/X-31 (A/X-31) and influenza virus A/Puerto Rico/8/34 (A/PR8) permits cross-reactivity of TH populations to be separable from B cell specificity: A/X-31 is a reassortant virus, which was constructed in Kilbourne’s laboratory to couple the vigorous growth characteristics of the H1N1 strain A/PR8 with the H3N2 serotype of Hong Kong epidemic influenza viruses (6). Accordingly, A/X-31 inherits six of eight genome segments from A/PR8, and two of eight, those encoding the hemagglutinin and neuraminidase (N) surface glycoproteins that define the serotype, from A/Aichi/2/68 (7). Because MHC class II molecules can be loaded with peptides derived from all viral components, A/X-31 and A/PR8 provoke extensively cross-reactive CD4+ T cell responses (8, 9, 10), and B cells specific for viral glycoproteins can receive help from MHC class II-restricted T cells specific for epitopes within the nucleocapsid core (11). These considerations help explain how, in early studies of heterosubtypic immunity between influenza A viruses, mice that had cleared one viral infection were observed to mount a more rapid and vigorous serum-neutralizing Ab response following challenge with a second serotypically unrelated virus (12). Naive B cells recruited into the primary response to H1 and N1 glycoproteins, following challenge with influenza virus A/PR8 of mice that have recovered from a respiratory infection with A/X-31, will thus receive help from memory TH cells primed in the context of the earlier infection.

We recently demonstrated that the quality of the Ab-forming cell (AFC) response of mice to a respiratory virus can depend critically upon its replicative capacity (13). We now examine the impact of cross-reactive TH populations, primed by pathogenic infection of mice by A/X-31, on the quality of a primary antiglycoprotein AFC response to replicationally inactivated A/PR8.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

Female C57BL/6J (B6) and B10.BR mice, obtained from The Jackson Laboratory (Bar Harbor, ME) were held under specific pathogen-free conditions until they were used at 10 to 14 wk of age.

Viruses

The origin of influenza viruses A/PR8 and A/X-31 is discussed below. Initial stocks of both strains were obtained from Dr. P. C. Doherty, and viruses were adapted to mice by series of intranasal (i.n.) passages of lung homogenates from infected mice. The A/X-31 stock was passaged five times through mice, and the A/PR8 stock twice, before use. Clarified homogenate stocks, stored at -70°C, had EID50 per milliliter titers as follows (EID50 is the reciprocal of dilution of inoculum required to infected 50% of embryonated chicken eggs): A/PR8, 3.7 x 107; A/X-31, 6.8 x 106. Virus to be used for inactivation or for Ag preparation was grown in the allantoic cavity of embryonated chicken eggs and purified by differential centrifugation and sucrose banding from high titer allantoic fluid stocks. Protein concentrations were determined by the method of Bradford (14). Purified virus in PBS was inactivated by treatment with 0.1% ß-propiolactone (BPL; Sigma, St. Louis, MO), 0.025 M Na2HPO4 at 37°C for 2 h. The mixture was then neutralized with NaHCO3, dialyzed overnight against PBS, and stored at -70°C. Purification of glycoproteins from viral particles was performed as described by Johansson et al. (15).

Immunizations and sampling

Mice were anesthetized with Avertin (2,2,2-tribromoethanol) given i.p. before all immunizations. Infectious and inactivated virus preparations were diluted in PBS, and a 30-µl volume was administered i.n. Mice were euthanized by CO2 inhalation. Superficial cervical and facial lymph nodes (LN) were collected from the cervical region and designated cervical lymph nodes (CLN). The right posterior mediastinal lymph node (MLN) was collected from the posterior thorax. LN nomenclature is based on Tilney (16). LNs were gently disrupted, and single cell suspensions were prepared in IMDM (Whittaker, Walkersville, MD) supplemented with L-glutamine (2 mM), sodium pyruvate (1 mM), penicillin (100 IU/ml), streptomycin (100 µg/ml), gentamicin (10 µg/ml), and 15% FCS (complete medium).

ELISPOT assay

The ELISPOT assay for Ag-specific AFC was done as previously described (17) using nitrocellulose-bottomed 96-well Multiscreen HA filtration plates (Millipore, Bedford, MA) coated with the appropriate viral Ags diluted in PBS, at 1.0 µg/well. After overnight incubation at 4°C, wells were washed and blocked with complete medium. Single cell suspensions were prepared in complete medium, and 100-µl volumes of appropriate dilutions were added to duplicate wells, typically using 1 to 5 x 105 cells/well. Incubation of the plates for 3 to 4 h at 37°C in a humid atmosphere containing 7% CO2 was followed by thorough washing. Alkaline phosphatase-conjugated isotype-specific goat anti-mouse Abs (Southern Biotechnology, Birmingham, AL) diluted 1:500 in PBS plus 5% BSA were added, and the plates were incubated overnight at 4°C. After extensive washing, spots were developed with 1 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (Sigma) in diethanolamine buffer typically for 1–2 h at room temperature, after which the plates were washed and dried. Blue spots reflecting Ab production by individual cells were counted using an Olympus SZH Stereozoom microscope (Olympus Optical, Tokyo, Japan).

It is critical for the correct interpretation of these experiments that AFC responses against glycoproteins of A/X-31 and A/PR8 be nonoverlapping, and not include any component directed against the nucleoplasmid core Ags that are common to both viruses, which could result from nucleoplasmid contamination of the purified glycoprotein preparations. Fig. 1Go demonstrates that this was achieved, by comparing the frequency of AFC developed in MLN of mice infected 7 days previously with A/X-31, scored on filters coated with glycoproteins prepared from A/X-31 viruses, with nucleoplasmid cores, or with glycoproteins purified from A/PR8 viruses.



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 1. Lack of apparent cross-reactivity in the AFC response to i.n. infection with influenza virus A/X-31. Anesthetized C57BL/6 mice were administered i.n. with A/X-31 in saline as described in Materials and Methods and sacrificed 7 days later, and MLN cells were assessed for the frequency of AFC secreting IgM, IgG, or IgA capable of binding to filters loaded with glycoproteins purified from A/X-31, with detergent-stripped nucleocapsid cores, or with glycoproteins purified from A/PR8, as indicated. Histograms show mean AFC frequencies as ELISPOTS per 200,000 MLN cells, derived from four mice, scored individually, with one SEM value shown as an error bar.

 

    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Experimental design

The rationale for these experiments requires the validity of two premises: 1) that the quality of the AFC response to i.n. infection with live influenza A virus differs significantly from that elicited by i.n. immunization with a similar virus preparation rendered inactive in replication; and 2) that the TH cells initially recruited into a response to influenza A/X-31 virus can provide effective help to naive antiglycoprotein-specific B cells activated by subsequent exposure to influenza A/PR8 virus. The data recovered from the whole experimental series are comprehensively tabulated, with statistical quantities, in Table IGo. Specific aspects of these data are illustrated and dissected in a more readily assimilable fashion in the following sections, which will establish the validity of the premises, and then address the major issue as to the capacities of memory TH cells. The statistical data in Table IGo indicate the considerable mouse-to-mouse variation encountered in these experiments, as implied by large, irreducible SDs; it has been necessary to perform these experiments with fairly large groups of mice to allow confident data interpretation. Not included in Table IGo are data from many control assays that established the high specificity of the AFC reactions: as demonstrated in Fig. 1Go, LN populations from infected mice that contained large numbers of AFC reactive with glycoproteins isolated from the infecting virus produced few or no signals when scored on filters coated with glycoproteins from the heterologous virus, thus confirming the lack of serological relatedness between A/PR8 and A/X-31, and the purity of the glycoprotein preparations.


View this table:
[in this window]
[in a new window]
 
Table I. Tabulation of all experimental data1

 
Respiratory infection with influenza A virus elicits a very different isotype distribution among antiviral AFC in draining LNs than does respiratory challenge with the same virus rendered replicationally incompetent

Fig. 2Go compares IgG, IgM, and IgA antiglycoprotein AFC responses elicited in MLN and in CLN of C57BL/6 mice administered i.n. with influenza viruses A/PR8 or A/X-31 in live or inactivated forms. (Inactivation was achieved by exposure to the alkylating agent BPL. In our experience, treatment with BPL, which acts principally through alkylation of RNA bases (18), results in complete inhibition of replicative capacity with much less severe effects on protein structure than do other means of viral inactivation: complete inactivation can be achieved with little or no impact on H titer, for example.) As expected from earlier work (13), responses induced by live viral infection considerably exceed those induced by inactivated virus (note the difference in histogram scale). Several other points emerge: 1) infectious and inactivated preparations elicit antiglycoprotein AFC populations that differ greatly in isotype distribution. Inactivated A/PR8 and A/X-31 both engender MLN responses in which switching to IgG is favored over switching to IgA (Fig. 2Go, A and B), while the reverse is true for CLN responses, IgA being preferred to IgG (Fig. 2Go, E and F). In contrast, administration of either infectious virus provokes a characteristic early (d7) MLN response featuring preferential switching to IgA (Fig. 2Go, C and D), while IgG is expressed by CLN antiglycoprotein AFC at a frequency comparable with IgA (Fig. 2Go, G and H). 2) The CLN response to A/PR8 infection is almost absent (Fig. 2GoG); in fact, the mean values shown in Fig. 2Go are due to a small number of mice that showed a late, breakthrough AFC response in CLN, more typically, no response was seen. Apart from this difference in the magnitude of the CLN response to infectious virus, the two viral strains generally resemble one another in the pattern of the AFC reactions they provoke. 3) The MLN antiglycoprotein AFC response shows a characteristic evolution during the course of acute infection with either live virus: the preferential expression of IgA over IgG evident (Fig. 2Go, C and D) 7 days after inoculation is reversed by 10 days postinoculation (d.p.i.) This evolution in expression of switched isotypes is not seen in the CLN response to live virus, nor in antiglycoprotein AFC reactions to inactivated virus at either site.



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 2. Antiglycoprotein AFC response to i.n. challenge with infectious or inactivated forms of influenza virus strains A/PR8 and A/X-31. Anesthetized C57BL/6 mice were administered i.n. with A/PR8 or A/X-31 in saline as described in Materials and Methods. Live, infectious forms of either virus had been serially passaged by growth in mouse lung; standard dose was 20 EID50 for A/PR8 and 200 EID50 for A/X-31. Inactivated forms had been exposed to ß-propiolactone; standard dose was 15 µg. Mice were sacrificed for sampling 7 or 10 d.p.i. Cell suspensions from CLN and MLN were scored for AFC directed against H1 and N1 glycoproteins of A/PR8, or H3 and N2 glycoproteins of A/X-31, and IgM, IgG or IgA Ab class was determined by ELISPOT assay using membranes loaded with glycoproteins purified from either virus. IgM and IgA spots were developed using single isotype-specific antisera, while IgG spots were developed using a mixture of antisera with approximately equivalent activity against all four IgG subclasses. Histograms show mean frequency of antiglycoprotein IgM, IgG, and IgA AFC generated in MLN and CLN 7 and 10 d.p.i. as ELISPOTS per 200,000 LN cells, with 1 SEM value indicated as an error bar. Note the difference in the axis scale between histograms showing responses to inactivated and to infectious viruses. Histogram bars representing AFC secreting IgM, plain bar with superscript letter M; secreting IgG, stippled bar with superscript letter G; secreting IgA, black bar with superscript letter A. A, MLN response to inactivated A/PR8; (B) MLN response to inactivated A/X-31; (C) MLN response to live A/PR8; (D) MLN response to live A/X-31; (E) CLN response to inactivated A/PR8; (F) CLN response to inactivated A/X-31; (G) CLN response to live A/PR8; and (H) CLN response to live A/X-31.

 
It should be noted that the mouse-passaged stocks of both of these influenza A strains are highly virulent for mice: the routine i.n. infectious dose used in these experiments (~20% of LD50 dose for C57BL/6 mice) was 200 EID50 of A/X-31, and only 20 EID50 of A/PR8. Clearly, inoculation with such small numbers of live viral particles must initially result in highly localized foci of infection, and it is possible that the evident difference between A/X-31 and A/PR8 in the anatomical distribution of AFC elicited simply reflects a difference in the distribution of the sites of initial infection: this is under current investigation.

Fig. 3Go shows in greater detail the time course of the antiglycoprotein AFC response in MLN and CLN to i.n. infection of C57BL/6 mice with live influenza A/PR8 and A/X-31, with sampling times 6,7, and 10 d.p.i. and the IgG response specified by subclass. None of the mice in this experimental group showed any significant CLN response to infection by A/PR8. The shift in isotype switch preference between day 7 and day 10 is again evident in MLN AFC populations. It can be seen that all four IgG subclasses contribute significantly to the overall IgG response to infection with either of these influenza viruses, both in MLN and (for A/X-31) in CLN. In this regard, the C57BL/6 response to infection by these influenza viruses resembles the response of this IgHb strain to Sendai virus (SV) infection (13, 19, 20), which was much less heavily skewed toward IgG2a expression than was seen in the IgHa mouse strain 129 (19). Other investigators have pointed out the complexity of the DNA sequence differences between the IgHa and IgHb haplotypes, and have suggested that C{gamma}2a genes in the IgHb haplotype be designated C{gamma}2c (21). Since C{gamma}2a genes within all described mouse CH haplotypes function as true alleles, we have not adopted this suggestion. Here, the roughly equivalent contribution of all IgG subclasses to the AFC response of C57BL/6 mice to infection with influenza A/PR8 and A/X-31 viruses suggests that little information is gained in these experiments by the dissection of IgG into subclasses. Since pooling IgG subclasses permits the scoring of significantly more LN cells per assay, it improves the quality of data recovered when the AFC response is not robust, as when inactivated virus is the immunogen. Therefore, in all such experiments, IgG subclasses were not separately enumerated, but were pooled as overall IgG.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 3. Kinetics of antiglycoprotein AFC response in MLN and CLN of mice infected i.n. with live influenza viruses A/PR8 or A/X-31. C57BL/6 mice were infected i.n. with A/PR8 or A/X-31 at the standard dose, and groups were sacrificed 6, 7, or 10 d.p.i. Antiglycoprotein AFC were enumerated by ELISPOT formation on filters coated with glycoproteins purified from A/PR8 or A/X-31. Spots were developed with isotype-specific antisera, and those containing IgM, IgG1, IG2a, IgG2b, IgG3, and IgA were counted separately. Histograms show means of AFC frequency per group, as spots per 200,000 input cells, with 1 SEM value shown as an error bar. Key to the marking of the histogram bars is shown on the upper right. A, MLN response to A/PR8 infection; (B) MLN response to A/X-31 infection; (C) CLN response to A/PR8 infection; and (D) CLN response to A/X-31 infection.

 
The primary AFC response against H1 and N1 viral glycoproteins following i.n. administration of inactivated A/PR8 is enhanced by previous infection with A/X-31

Given that A/X-31 and A/PR8 influenza viruses elicit extensively cross-reactive Ag-specific CD4+ T cell populations, it might be anticipated that the B cell, and AFC, response to the glycoproteins of A/PR8 of mice that had recovered from infection with A/X-31 should be enhanced compared with the response of naive mice. Fig. 4Go demonstrates that this is the case. C57BL/6 mice that had cleared a respiratory infection with A/X-31 mounted a significantly more robust antiglycoprotein AFC response to i.n. inactivated A/PR8 than did naive mice. Total AFC frequencies are severalfold higher 7 d.p.i., both in CLN and in MLN of A/X-31 immune animals than in naive mice. Moreover, the kinetic pattern of the response at both sites indicates effective priming by A/X-31 infection, since the anti-H1/N1 AFC reaction diminished considerably between 7 d.p.i. and 10 d.p.i. in CLN and MLN of A/X-31 immune mice while being maintained or increasing at both sites in naive mice.



View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 4. Anti-A/PR8 glycoprotein AFC response in MLN and CLN of mice immunized i.n. with inactivated influenza virus A/PR8, comparing naive mice to mice previously infected with A/X-31. Inactivated A/PR8 was administered i.n. at standard dose to groups of C57BL/6 mice, comparing naive mice with mice that had recovered from an infection, ~6 wk previously, with live A/X-31. Mice were sacrificed 7 and 10 days following the A/PR8 challenge, and MLN and CLN were recovered and scored for AFC directed against H1/N1 glycoproteins from A/PR8. The chart shows the mean frequency of AFC of all isotypes enumerated as ELISPOTS per 200,000 input cells, with 1 SEM value shown as an error bar in (A) MLN; (B) CLN, 7 and 10 days postimmunization, with naive and A/X-31-immune groups on the same axes. Naive mice, stippled bar with superscript letter N; A/X-31 immune mice, striped bar with superscript letter I.

 
Mice previously infected with A/X-31 mount a secondary-type AFC response to Ags of the nucleocapsid core, when immunized with inactivated A/PR8

Since the internal, nucleocapsid core structures should be identical in viruses A/X-31 and A/PR8, mice that have recovered from infection by A/X-31 are expected to possess primed, memory lymphocytes specific for nucleocapsid core Ags within both T and B cell subsets. Such mice should therefore mount a secondary-type AFC reaction against Ags within the nucleocapsid core when immunized with inactivated A/PR8, AFC being derived from memory B cell populations. Fig. 5Go shows that the anti-nucleocapsid AFC response to inactivated A/PR8 is very greatly enhanced by earlier infection with A/X-31, and that it is already dominated by the switched isotypes IgG and IgA 7 d.p.i. in A/X-31 immune mice.



View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 5. AFC specific for core nucleocapsid Ags following immunization with inactivated A/PR8, comparing naive mice to mice previously infected with A/X-31. As in Fig. 3Go, a group of naive C57BL/6 mice and a group of mice that had recovered from an earlier infection with A/X-31 were immunized i.n. with inactivated A/PR8. MLN and CLN were scored for AFC directed against Ags within detergent-stripped core nucleocapsids isolated from A/X-31, 7 and 10 days after the A/PR8 immunization. The histogram shows the mean frequency of anti-nucleocapsid AFC secreting IgM, IgG, and IgA assessed as ELISPOTS per 200,000 input cells, with 1 SEM value shown as an error bar. IgM, plain bar with superscript letter M; IgG, stippled bar with superscript letter G; IgA, black bar with superscript letter A. A, MLN, naive mice; (B) MLN, X-31 immune mice; (C) CLN, naive mice; and (D) CLN, X-31 immune mice.

 
Previous infection with A/X-31 does not greatly alter the isotype distribution of the primary AFC response against H1 and N1 glycoproteins following i.n. administration of inactivated A/PR8

The observations reported above constitute the two necessary premises for determining whether the context of TH priming must be the major determinant of the quality of an Ab response. A/X-31 infection primes TH cells that provide effective help to naive B cells specific for A/PR8 glycoproteins; and the pattern of isotype expression among MLN and CLN antiglycoprotein AFC is markedly different in the response to inactivated A/PR8 particles from that provoked by infection with live A/PR8. Moreover, the quality of antiglycoprotein AFC responses provoked by both infectious and inactivated forms of either virus exhibits a strong dependence on anatomical location that is particularly marked in the case of inactivated preparations, and is of an opposite trend for live and inactivated forms. If the circumstances of the initial recruitment of TH cells is the primary determinant of the quality of subsequent immune responses that draw upon those TH cells, then the preferential expression, in antiglycoprotein AFC populations provoked in naive mice by i.n. administration of inactivated A/PR8, of IgG over IgA in MLN, and IgA over IgG in CLN, should be substantially altered in mice that have cleared an infection with A/X-31. This experimental plan is shown in cartoon form in Fig. 6Go, and relevant data in Figs. 7Go and 8.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 6. Experimental strategy to determine whether TH populations primed by a response to live influenza A virus infection are limited with regard to the quality of the AFC responses that they can support. A, The response to live influenza A infection. Isotype switching preferences of antiglycoprotein B cells in MLN and CLN are indicated by the relative sizes of "IgA" and "IgG." Tn, Naive TH cell; Bn, naive B cell. Glycoprotein structures recognized by B cells and Abs are shown on the outside of the virus symbols. Nucleocapsid core epitopes recognized by cross-reactive TH cells are shown within the virus symbols. B, The response to inactivated i.n. influenza A particles. C, The two sequential responses of the experimental situation, above, to live influenza A infection, which primes cross-reactive TH cells and repeats the isotype-switching pattern known to occur in A, and, below, the subsequent response to inactivated influenza A particles, which involves naive B cells but memory TH cells (Tm), which were primed by the earlier infection. The resultant isotype switching pattern was unknown and is the subject of these experiments.

 


View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 7. Anti-A/PR8 glycoprotein AFC response to i.n. immunization with inactivated A/PR8 of mice previously infected with live influenza virus A/X-31. C57BL/6 mice that had cleared an i.n. infection with A/X-31 several wk previously were immunized i.n. with inactivated A/PR8, and LN were scored for AFC directed against the A/PR8 H1 and N1 glycoproteins. Histograms show the mean frequencies of antiglycoprotein AFC secreting IgM, IgG, and IgA as ELISPOTS per 200,000 input cells 7 days and 10 days after the A/PR8 immunization, with 1 SEM value shown as an error bar. IgM, plain bar with superscript letter M; IgG, stippled bar with superscript letter G; IgA, black bar with superscript letter A. A, MLN response; B, CLN response.

 
Data presented in Fig. 7Go reveal that the pattern of isotype switching shown by H1/N1-specific B cells in MLN of C57BL/6 mice responding to inactivated A/PR8 given i.n. is not greatly altered by previous infection with A/X-31 (compare Fig. 7GoA with Fig. 2GoA); isotype switching is considerably skewed toward IgG in both naive and A/X-31 immune mice, in marked contrast to the initial IgA skew observed during the response to A/X-31 infection. Switching to IgA remains relatively much more likely in the less vigorous antiglycoprotein CLN response to inactivated A/PR8 of A/X-31 immune mice, as in naive mice, although a higher incidence of AFC-secreting IgG in A/X-31 immune mice than naive mice may point to a lingering influence of the earlier infection (compare Fig. 7GoB with Fig. 2GoE). In general, however, the strong regional discrimination in the quality of the antiglycoprotein AFC response to inactivated A/PR8 remains unaltered by, and sharply distinguished from, that of the local AFC reactions characteristically induced by the earlier A/X-31 infection.

Fig. 8Go shows part of the same set of data in a manner that takes into account the mouse-to-mouse variability referred to above that is subsumed into the mean values shown in Fig. 7Go. In Fig. 8Go, isotype switching tendency for MLN and CLN antiglycoprotein AFC responses of each individual animal is displayed as an IgG:IgA ratio, thus independently of magnitude. The same trends can be discerned: expression of IgA is favored 7 d.p.i. in MLN of mice infected with A/X-31, while in CLN of the same mice, expression shows a mild skew toward IgG; trends are reversed in naive mice administered i.n. with inactivated A/PR8, which show pronounced skews toward IgG in MLN, IgA in CLN. In this figure, the critical data points from the "memory" mice, initially infected with live A/X-31 and subsequently immunized with inactivated A/PR8, can be clearly seen to fall comfortably into the ranges obtained from naive mice administered with inactivated A/PR8, and not with infectious A/X-31. Statistical analysis confirmed the impression of a highly significant difference in switched isotype expression between antiglycoprotein AFC populations induced in MLN 7 d.p.i. by inactivated A/PR8 in A/X-31 immune mice and live A/X-31 in naive mice.



View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 8. Comparison of isotype-switching preference in MLN and CLN of C57BL/6 mice administered i.n. with influenza virus in various forms, showing ratios of antiglycoprotein AFC secreting IgG to those secreting IgA for individual mice 7 days postimmunization. Data from each mouse are shown as a dot indicating the ratio of IgG:IgA expression among antiglycoprotein AFC determined as ELISPOTS. IgG, IgA ratio is shown on a logarithmic scale on the axis. CLN and MLN responses are compared for naive mice that received live A/X-31, assessed on A/X-31 glycoproteins; naive mice that received inactivated A/PR8, assessed on A/PR8 glycoproteins; or mice that were initially infected with live A/X-31 then, several wk later, immunized with inactivated A/PR8, assessed on A/PR8 glycoproteins. Treatment of these data by ANOVA and t test indicated antiglycoprotein AFC populations elicited in MLN by live A/X-31 infection of naive mice, and by inactivated A/PR8 immunization of A/X-31 immune mice, to differ in isotype expression with a p value of 0.01.

 
The overall kinetic pattern of the antiglycoprotein AFC response of A/X-31 memory mice to inactivated A/PR8 is that expected of a primary B cell response, with a sharply diminishing contribution of IgM over the course of the reaction (Fig. 7Go), contrasting with the secondary-type response observed in the same mice to Ags within the nucleocapsid core (Fig. 5Go).

B10.BR mice generally resemble C57BL/6 mice in the influence of heterosubtypic infection on the response to inactivated virus

To ensure that our conclusions were not unduly influenced by some unsuspected idiosyncrasy in the response of C57BL/6 mice to influenza A, we performed the same experiments, on a smaller scale, in B10.BR mice, which are genotypically H2k and thus will involve a completely separate set of viral epitopes in their TH response to the virus. The data obtained, which are listed in Table IGo but not otherwise graphed, reinforced the impression derived from the more extensive C57BL/6 experiments. The response patterns of naive mice to i.n. administration of infectious A/X-31 and of inactivated A/PR8 recapitulate themes seen in C57BL/6. There is a strong initial switching preference toward IgA evident in the day 7 MLN response to infectious A/X-31 that shifts markedly by day 10; and B cells responding to inactivated A/PR8 are much more likely to switch to IgG in MLN than in CLN. The antiglycoprotein response induced by inactivated A/PR8 in mice that had recovered from an earlier A/X-31 infection, which was sampled only 7 d.p.i., shows that the prior infection results in a day 7 MLN and CLN AFC response increased in magnitude, but unaltered in the pattern of isotype switching, which is characteristic of that induced in naive mice by inactivated, rather than live, virus.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Over the last decade, a very broadly held consensus has emerged: generally, about the association of different effector functions with differentiated sets of TH cells; and in particular, about how these direct the isotype commitment of B cells newly engaged in immune responses. Naive CD4+ cells are held to emerge from the thymus uncommitted as to the effector status of their differentiated progeny. Upon encounter with Ag they are believed to choose one of a limited number of developmental options, the choice being directed by the circumstances of that encounter, including the nature of the cell presenting Ag and the nature of the Ag itself. Generally, two options are recognized: TH1 cells, which retain the ability to secrete IL2 and IFN-{gamma}; and TH2 cells, which secrete preferentially IL-4, IL-5, and IL-10. However, most of the available information about the biology and phenotypic stability of TH1 and TH2 cells derives from studies in tissue culture. This limitation, as well as the inherent a priori unlikeliness that only two positions should ever be occupied in the n-dimensional hyperspace theoretically implied by the capacity of TH cells to express n variable effector phenotypic quantities, has led some to doubt whether the TH1/TH2 paradigm allows an accurate description of the physiological behavior of TH cells in vivo (22, 23).

The pattern of isotypes expressed by B cells responding to the initial appearance of Ag is also considered a direct outcome of the circumstances of Ag encounter by naive CD4+ T cells, since isotype commitment by activated B cells is understood to be dictated by the particular mixture of cytokines secreted by the TH cells providing help (1). In mice, production of Ag-specific IgG2a is considered a distinguishing trait of a response dominated by TH1 cells, while IgG1 expression results from TH2 dominance. These arguments are so well established that it has become commonplace to refer to the "TH1" or "TH2" character of an immune response, given only the isotype distribution of the AFC response (2).

Taken together, these two precepts imply that the quality of an Ab response that depends on naive B cells encountering an Ag for the first time must be determined by the conditions under which the TH cells recruited to help that response were initially primed. Unless a stringent correlation is maintained between B and TH recognition of foreign Ags—that is, that TH cross-reactivity is very rare—B cells responding to a newly encountered Ag could be directed into a response entirely mismatched in quality to the the new Ag, by preexisting memory TH cells initially primed under qualitatively distinct circumstances. Mason has recently reviewed the evidence that individual MHC class II-restricted TH cells can react with a diversity of peptide structures (4), pointing out that simple arithmetical considerations of the size of TH populations in vivo and the repertoire of Ag-receptor structures available to them render an absolute specificity of a single TH cell for a single peptide unsustainable; in fact, TH cross-reactivity is common. The experiments described above were designed to discover the effect of TH cross-reactivity on the compartmentalization of antiviral Ab responses.

In an earlier report, we noted that the pattern of isotype expression in the antiviral AFC response elicited in CLN of mice by i.n. deposition of SV was highly dependent on the biological activity of the virus; inactivated SV provoked a response characterized by the almost exclusive expression of IgA, while IgG expression was favored in the more robust response to live, pathogenic SV (13). That such effects can be strictly compartmentalized was evident in that the IgA-dominated anti-SV response provoked in CLN by SV given i.n. was completely unperturbed by the much more vigorous IgG-skewed response at the same site to i.n. infectious influenza virus A/X-31 in mice that had received both viruses simultaneously. Here we have exploited the segmented nature of the influenza virus genome, which permits dissection of B and TH target Ags by the use of reassortant viruses. This feature, coupled with the dependence of the quality of an antiviral AFC response on the biological activity of the virus, has allowed us to investigate the influence of an established memory TH population upon the pattern of a naive B cell response. Will memory TH cells, primed in the exacting context of an immune response to pathogenic respiratory infection with a live virus, imbue naive B cells responding to inactivated virus with the quality of a response to live viral infection; or will the regional character that shapes the B cell response of naive mice to inactivated virus remain the dominant influence?

Data presented above clearly demonstrate the latter result. The antiglycoprotein AFC reaction to i.n. inactivated A/PR8 was considerably larger and faster in mice that had cleared an earlier A/X-31 infection than in naive mice, presumably due to help from cross-reactive TH cells; however, though IgG expression was somewhat more likely in the minor CLN response of A/X-31 immune mice than naive mice, both it and the major MLN response continued to show the marked regional influence characteristic of the reaction in naive mice. AFC reactive with A/PR8 glycoproteins were much more likely to express IgA in CLN than MLN, while MLN AFC were much more likely to express IgG than IgA, trends very distinct from those engendered by live influenza viral infection.

In light of the predominant consensus support for the twin arguments that predict that the circumstances of TH priming should have a profound impact on the quality of subsequent Ab responses—namely, that TH commitment to lymphokine secretion profile is early and stable and that isotype switch choice is directed by TH cytokine concentrations—one must ask why no such impact was evident. One set of answers revolves around the trivial case; namely, that the response to inactivated A/PR8 did not, in fact, include critical TH populations primed by A/X-31 infection. In this regard, it should be noted that primed TH populations can indeed contribute significantly to protective immunity from influenza virus infection by helping Ab responses from naive B cells; cloned TH cells adoptively transferred into histocompatible nude mice enabled recipients to resist lethal viral challenge and to clear the virus (24), an effect not seen after challenge of similarly engrafted SCID recipients, which, lacking B cells, were unable to mount an Ab response. It must be admitted that our experimental design necessarily involves only a partial recruitment of the TH cells primed during the initial infection with live A/X-31; those cells specific for glycoprotein peptides absent from A/PR8 will, of course, not be mobilized by the challenge with the latter viral strain. We doubt that the participation of such clones would result in responses much altered from those reported above for the case of incomplete TH cross reactivity, but direct data is, perforce, lacking, and the individual TH clones specific for determinants within HA, M and NP influenza viral proteins described by Scherle and Gerhard (25), did vary in their ability to support isotype switching.

However, we think rather that the answer to this question lies in the aforementioned promiscuity of TH cells; it seems inescapable that the regulatory mechanisms employed by mammalian immune systems to optimize the matching of Ab class to the type of pathogen encountered, and its route of invasion, evolved in a context of extensive TH cross-reactivity. The powerful nature of the effector clearing mechanisms to which the various Ab classes are differentially linked imposes a stringent need to ensure that pathogen invasion is met by an an Ab response of the appropriate quality. The probability, implied by TH cross-reactivity, that TH cells primed in a response to one type of pathogen would be subsequently recruited into an immune response to a completely different type of pathogen strongly suggests a selection pressure to evolve additional proof-reading measures that can be applied to reinforce an appropriate match of Ab class with pathogen type.

This argument is simply the obverse of that used to support the theory of molecular mimicry as the basis of immunopathological disease; peptide sequences similar to those recognized by T cells activated in response to a diversity of pathogens can readily be found sprinkled throughout the sequences of self, or unrelated foreign, Ags (5, 26). We do not intend to suggest that the T cell response to such peptides never results in immunopathological consequences or qualitatively inappropriate immune responses; only that such undesirable reactions are normally held in check by the extra proof-reading mechanisms here envisaged to have evolved specifically to preclude uncontrolled spillover effects between separate immune responses.

Our earlier observations, particularly of the overriding importance of the site of deposition of inactivated SV for the isotype-switching preference of antiviral B cells in CLN (13), led us to suggest that Ag-transporting dendritic cells (DC) might function to insulate and compartmentalize distinct immune responses within a single node. Since the primary function of DC, by definition, is to activate naive T cells, this compartmental role was most simply envisaged as an interaction, within the draining LN, with Ag-specific CD4+ T cells that recognize viral peptides complexed with MHC class II molecules on the DC surface, and at the same time receive information from the DC about its site of origin and the nature of the Ags carried, which would be used to program the expression of an appropriate pattern of TH cytokines. TH cells thus instructed could then collaborate in a cognate fashion with virus-specific B cells and impose on them a suitable isotype switch preference. The results presented here strongly suggest that the putative instructional role of DC is not encompassed by one quantal event during which TH clonal founders have stamped on them some definite immunoregulatory program that they can execute at another site.

Rather, these new data fit better with the notion that the influence of DC on TH function, while powerful, is limited, certainly in time, and perhaps also in space; TH cells may be imagined as decoding information from DC as to the nature of the Ag they carry and its site of entry, and flexibly "interpreting" this information for Ag-specific B cells in their immediate vicinity. On this theory, alterations in the anatomical distribution of the principal sites of Ag acquisition by DC during the course of a spreading infection might be expected, after some lag, to be reflected in an altered pattern of immune response; we consider it likely that this accounts for the shift in isotype switch preference evident in the MLN antiglycoprotein AFC response between day 7 and day 10 after i.n. infection with live influenza virus. Such a shift would not be expected, and is not seen, during the response to i.n. deposition of inactivated virus, where the much larger initial dose of immunizing Ag would be expected to result in a more anatomically uniform distribution of Ag.

Recent work has convincingly demonstrated significant direct interactions between DC and B cells (27, 28, 29), including the induction by DC, in the absence of T cells, of isotype switching in activated B cells. While T cells, and interaction between TH surface CD40 ligand and B cell surface CD40, are indispensable for effective in vivo class switching by B cells specific for protein Ags, perhaps such direct interactions amplify or modulate cognate TH-B interplay within multicell assemblages during the recruitment phase of the B cell response in LNs, resembling the long-known DC-T-B clusters that can form when these cells are cocultured (30). DC not only very efficiently present TH epitopes complexed with MHC class II molecules, but also have the capacity to retain protein Ags in a native form (27) available to bind specifically to B cell surface Ig. DC appearing in draining LNs may thus be equipped to recruit both naive Ag-specific TH and B cells into such clusters, responding respectively to processed and native forms of the same Ag. In the case of influenza glycoproteins, DC may not require any special means of native Ag retention, since infected DC express large numbers of these proteins, newly synthesized, on their surface, perhaps partially accounting for the high immunogenicity of these viruses, when infectious. Note that DC appear also to be particularly resistant to the cytopathic effects of influenza viruses (31), perhaps lengthening the time for them to initiate immune reactions in draining LN, having been infected at mucosal surfaces. Whatever the nature of the physical association between DC, TH, and B cells, data presented above contradict the idea that the quality of the Ab response to influenza A virus infection of mice is dictated by virus-specific TH clones irrevocably committed only to support responses of a similar quality; the TH clones that help virus-specific B cells make the isotype switches so characteristic of the local response to a live influenza A infection retain the ability to help other B cells make other choices, in response to other DC populations transporting other Ags.

It is certainly not the case that TH cells never retain any imprint of quality of their priming stimulus. In our own study of the cytokine-secreting ability of SV-specific TH cells, we noted that such cells when elicited by live SV infection secreted much more IFN-{gamma} upon restimulation in vitro than similar cells primed by immunization with inactivated SV (13), and a similar polarization may be reflected in the increased incidence of IgG among antiglycoprotein AFC induced in CLN by inactivated A/PR8 in mice that have cleared an A/X-31 infection. Highly polarized TH cells, irrevocably committed to TH1 or TH2 secretion patterns, perhaps by manyfold repeated stimulus (32), may well underlie immunopathological states. But our observations argue strongly that such stable commitment is not normally an immunoregulatory mode of overriding importance, at least in the response of mice to influenza A infection.


    Acknowledgments
 
We thank Dr. P. C. Doherty for supplying virus stocks and Dr. J. L. Hurwitz for helpful discussion.


    Footnotes
 
1 This work was supported by Public Health Service Grant AI39028 and by the American Lebanese-Syrian Associated Charities. Back

2 Address correspondence and reprint requests to Dr. Christopher Coleclough, Department of Immunology, St. Jude Children’s Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105-2794. Back

3 Abbreviations used in this paper: H, hemagglutinin; AFC, Ab-forming cell; LN, lymph node; CLN, cervical LN; MLN, posterior mediastinal LN; i.n., intranasal(ly); A/PR8, influenza virus A/Puerto Rico/8/34; A/X-31, influenza virus A/HK/X-31; N, neuraminidase; EID50, viral titer as the reciprocal of dilution that will infect 50% of inoculated embryonated chick eggs; BPL, ß-propiolactone; SV, Sendai virus; d.p.i., days postinoculation; DC, dendritic cell; ELISPOT, enzyme-linked immunospot. Back

Received for publication June 4, 1999. Accepted for publication August 10, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Stavnezer, J.. 1996. Antibody class switching. Adv. Immunol. 61:79.[Medline]
  2. Toellner, K. M., S. A. Luther, D. M. Sze, R. K. Choy, D. R. Taylor, I. C. M. MacLennan, H. Acha-Orbea. 1998. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J. Exp. Med. 187:1193.[Abstract/Free Full Text]
  3. Caton, A. J., W. Gerhard. 1992. The diversity of the CD4+ T cell response in influenza. Semin. Immunol. 4:85.[Medline]
  4. Mason, D.. 1998. A very high level of cross-reactivity is an essential feature of the T-cell receptor. Immunol. Today 19:395.[Medline]
  5. Oldstone, M. B.. 1998. Molecular mimicry and immune-mediated diseases. FASEB J. 12:1255.[Abstract/Free Full Text]
  6. Kilbourne, E. D., J. L. Schulman, G. C. Schild, G. Schloer, J. Swanson, D. Bucher. 1971. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J. Infect. Dis. 124:449.[Medline]
  7. Baez, M., P. Palese, E. D. Kilbourne. 1980. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J. Infect. Dis. 141:362.[Medline]
  8. Hurwitz, J. L., C. J. Hackett, E. C. McAndrew, W. Gerhard. 1985. Murine TH response to influenza virus: recognition of hemagglutinin, neuraminidase, matrix, and nucleoproteins. J. Immunol. 134:1994.[Abstract]
  9. Katz, J. M., W. G. Laver, D. O. White, E. M. Anders. 1985. Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains. J. Immunol. 134:616.[Abstract]
  10. Katz, J. M., L. E. Brown, R. A. Ffrench, D. O. White. 1985. Murine helper T lymphocyte response to influenza virus: recognition of haemagglutinin by subtype-specific and cross- reactive T cell clones. Vaccine 3:257.[Medline]
  11. Scherle, P. A., W. Gerhard. 1988. Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. Proc. Natl. Acad. Sci. USA 85:4446.[Abstract/Free Full Text]
  12. Schulman, J. L., E. D. Kilbourne. 1965. Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J. Bacteriol. 89:170.[Abstract/Free Full Text]
  13. Sangster, M. Y., X. Y. Mo, R. Sealy, C. Coleclough. 1997. Matching antibody class with pathogen type and portal of entry: cognate mechanisms regulate local isotype expression patterns in lymph nodes draining the respiratory tract of mice inoculated with respiratory viruses, according to virus replication competence and site of inoculation. J. Immunol. 159:1893.[Abstract]
  14. Bradford, M. M.. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.[Medline]
  15. Johansson, B. E., D. J. Bucher, E. D. Kilbourne. 1989. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J. Virol. 63:1239.[Abstract/Free Full Text]
  16. Tilney, N. L.. 1971. Patterns of lymphatic drainage in the adult laboratory rat. J. Anat. 109:369.[Medline]
  17. Sarawar, S. R., M. Sangster, R. L. Coffman, P. C. Doherty. 1994. Administration of anti-IFN-{gamma} antibody to ß2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a Th2 phenotype. J. Immunol. 153:1246.[Abstract]
  18. Colburn, N. H., R. G. Richardson, R. K. Boutwell. 1965. Studies of the reaction of ß-propiolactone with deoxyguanosine and related compounds. Biochem. Pharmacol. 14:1113.[Medline]
  19. Hyland, L., M. Sangster, R. Sealy, C. Coleclough. 1994. Respiratory virus infection of mice provokes a permanent humoral immune response. J. Virol. 68:6083.[Abstract/Free Full Text]
  20. Sangster, M., L. Hyland, R. Sealy, C. Coleclough. 1995. Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments. Virology 207:287.[Medline]
  21. Martin, R. M., A. M. Lew. 1998. Is IgG2a a good Th1 marker in mice?. Immunol. Today 19:49.[Medline]
  22. Kelso, A.. 1995. Th1 and Th2 subsets: paradigms lost?. Immunol. Today 16:374.[Medline]
  23. Allen, J. E., R. M. Maizels. 1997. Th1-Th2: reliable paradigm or dangerous dogma?. Immunol. Today 18:387.[Medline]
  24. Scherle, P. A., G. Palladino, W. Gerhard. 1992. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148:212.[Abstract]
  25. Scherle, P. A., W. Gerhard. 1986. Functional analysis of influenza-specific helper T cell clones in vivo: T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J. Exp. Med. 164:1114.[Abstract/Free Full Text]
  26. Wucherpfennig, K. W., J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.[Medline]
  27. Wykes, M., A. Pombo, C. Jenkins, G. G. MacPherson. 1998. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161:1313.[Abstract/Free Full Text]
  28. Fayette, J., B. Dubois, S. Vandenabeele, J. M. Bridon, B. Vanbervliet, I. Durand, J. Banchereau, C. Caux, F. Briere. 1997. Human dendritic cells skew isotype switching of CD40-activated naive B cells toward IgA1 and IgA2. J. Exp. Med. 185:1909.[Abstract/Free Full Text]
  29. Dubois, B., B. Vanbervliet, J. Fayette, C. Massacrier, C. Van Kooten, F. Briere, J. Banchereau, C. Caux. 1997. Dendritic cells enhance growth and differentiation of CD40- activated B lymphocytes. J. Exp. Med. 185:941.[Abstract/Free Full Text]
  30. Inaba, K., M. D. Witmer, R. M. Steinman. 1984. Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells during primary antibody responses in vitro. J. Exp. Med. 160:858.[Abstract/Free Full Text]
  31. Bender, A., M. Albert, A. Reddy, M. Feldman, B. Sauter, G. Kaplan, W. Hellman, N. Bhardwaj. 1998. The distinctive features of influenza virus infection of dendritic cells. Immunobiology 198:552.[Medline]
  32. Murphy, E., K. Shibuya, N. Hosken, P. Openshaw, V. Maino, K. Davis, K. Murphy, A. O’Garra. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:901.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
S. C. Jones, K. Clise-Dwyer, G. Huston, J. Dibble, S. Eaton, L. Haynes, and S. L. Swain
Impact of Post-Thymic Cellular Longevity on the Development of Age-Associated CD4+ T Cell Defects
J. Immunol., April 1, 2008; 180(7): 4465 - 4475.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Rangel-Moreno, D. M. Carragher, R. S. Misra, K. Kusser, L. Hartson, A. Moquin, F. E. Lund, and T. D. Randall
B Cells Promote Resistance to Heterosubtypic Strains of Influenza via Multiple Mechanisms
J. Immunol., January 1, 2008; 180(1): 454 - 463.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Yao, R. Zhang, L. Guo, M. Li, and C. Chen
Th Cell-Independent Immune Responses to Chimeric Hemagglutinin/Simian Human Immunodeficiency Virus-Like Particles Vaccine
J. Immunol., August 1, 2004; 173(3): 1951 - 1958.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Y. Sangster, J. M. Riberdy, M. Gonzalez, D. J. Topham, N. Baumgarth, and P. C. Doherty
An Early CD4+ T Cell-dependent Immunoglobulin A Response to Influenza Infection in the Absence of Key Cognate T-B Interactions
J. Exp. Med., October 6, 2003; 198(7): 1011 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Oh and M. C. Eichelberger
Polarization of Allogeneic T-Cell Responses by Influenza Virus-Infected Dendritic Cells
J. Virol., September 1, 2000; 74(17): 7738 - 7744.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, D.
Right arrow Articles by Coleclough, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, D.
Right arrow Articles by Coleclough, C.